BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 14745307)

  • 1. Chronic ethanol consumption reduces delta-and mu-opioid receptor-stimulated G-protein coupling in rat brain.
    Saland LC; Abeyta A; Frausto S; Raymond-Stintz M; Hastings CM; Carta M; Valenzuela CF; Savage DD
    Alcohol Clin Exp Res; 2004 Jan; 28(1):98-104. PubMed ID: 14745307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chronic ethanol and withdrawal on the mu-opioid receptor- and 5-Hydroxytryptamine(1A) receptor-stimulated binding of [(35)S]Guanosine-5'-O-(3-thio)triphosphate in the fawn-hooded rat brain: A quantitative autoradiography study.
    Chen F; Lawrence AJ
    J Pharmacol Exp Ther; 2000 Apr; 293(1):159-65. PubMed ID: 10734165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ethanol self-administration on mu- and delta-opioid receptor-mediated G-protein activity.
    Sim-Selley LJ; Sharpe AL; Vogt LJ; Brunk LK; Selley DE; Samson HH
    Alcohol Clin Exp Res; 2002 May; 26(5):688-94. PubMed ID: 12045478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic antidepressant treatment causes a selective reduction of mu-opioid receptor binding and functional coupling to G Proteins in the amygdala of fawn-hooded rats.
    Chen F; Lawrence AJ
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1020-6. PubMed ID: 15121763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine alters mu but not delta or kappa opioid receptor-stimulated in situ [35S]GTPgammaS binding in rat brain.
    Schroeder JA; Niculescu M; Unterwald EM
    Synapse; 2003 Jan; 47(1):26-32. PubMed ID: 12422370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic ethanol modulates delta and mu-opioid receptor expression in rat CNS: immunohistochemical analysis with quantitiative confocal microscopy.
    Saland LC; Hastings CM; Abeyta A; Chavez JB
    Neurosci Lett; 2005 Jun 10-17; 381(1-2):163-8. PubMed ID: 15882810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu and delta opioid-stimulated [35S]GTP gamma S binding in brain and spinal cord of polyarthritic rats.
    Cichewicz DL; Cox ML; Welch SP; Selley DE; Sim-Selley LJ
    Eur J Pharmacol; 2004 Nov; 504(1-2):33-8. PubMed ID: 15507218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
    Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mu opioid receptor coupling to Gi/o proteins increases during postnatal development in rat brain.
    Talbot JN; Happe HK; Murrin LC
    J Pharmacol Exp Ther; 2005 Aug; 314(2):596-602. PubMed ID: 15860573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of mu opioid receptor/G-protein desensitization in brain by chronic heroin administration.
    Maher CE; Martin TJ; Childers SR
    Life Sci; 2005 Jul; 77(10):1140-54. PubMed ID: 15890372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects.
    Szekeres PG; Traynor JR
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1276-84. PubMed ID: 9400003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional reduction in mu-opioidergic system in the spinal cord under a neuropathic pain-like state following chronic ethanol consumption in the rat.
    Narita M; Miyoshi K; Narita M; Suzuki T
    Neuroscience; 2007 Feb; 144(3):777-82. PubMed ID: 17156932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intracerebroventricular administration of beta-funaltrexamine on DAMGO-stimulated [35S]GTP-gamma-S binding in rat brain sections.
    Martin TJ; Sim LJ; Selley DE; deMontis MG; Childers SR
    Synapse; 1997 Nov; 27(3):177-82. PubMed ID: 9329153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
    Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between delta-opioid receptor functional response and autoradiographic labeling in rat brain and spinal cord.
    Pradhan AA; Clarke PB
    J Comp Neurol; 2005 Jan; 481(4):416-26. PubMed ID: 15593339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colocalization of mu-opioid receptors and activated G-proteins in rat cingulate cortex.
    Vogt LJ; Sim-Selley LJ; Childers SR; Wiley RG; Vogt BA
    J Pharmacol Exp Ther; 2001 Dec; 299(3):840-8. PubMed ID: 11714867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced striatal opioid receptor-mediated G-protein activation in L-DOPA-treated dyskinetic monkeys.
    Chen L; Togasaki DM; Langston JW; Di Monte DA; Quik M
    Neuroscience; 2005; 132(2):409-20. PubMed ID: 15802193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoradiographic distribution of mu-, delta- and kappa 1-opioid stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in human frontal cortex and cerebellum.
    Platzer S; Winkler A; Schadrack J; Dworzak D; Tölle TR; Zieglgänsberger W; Spanagel R
    Neurosci Lett; 2000 Apr; 283(3):213-6. PubMed ID: 10754225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.